Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOxTROT - Neoadjuvant Chemotherapy for Colon Cancer
NCT00647530Phase 3Unknown
- Sponsor
- University of Birmingham
- Start
- May 2008
- Primary completion
- Dec 2016
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of panitumumab in colon cancer, sponsored by University of Birmingham. Status: unknown.
02
Drugs
panitumumab
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT00647530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00647530.